Maverick Capital’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,318,700
Closed -$51.1M 543
2022
Q4
$51.1M Sell
4,318,700
-3,383,170
-44% -$24.6M 1.24% 24
2022
Q3
$45.6M Buy
7,701,870
+954,321
+14% +$6.26M 1.03% 20
2022
Q2
$28.7M Buy
6,747,549
+69,823
+1% +$436K 0.72% 32
2022
Q1
$63.5M Buy
6,677,726
+642,851
+11% +$7.44M 1.14% 23
2021
Q4
$115M Buy
6,034,875
+2,738,424
+83% +$71.1M 1.39% 19
2021
Q3
$110M Buy
3,296,451
+475,372
+17% +$14.7M 1.21% 20
2021
Q2
$109M Sell
2,821,079
-150,057
-5% -$5.89M 1.03% 19
2021
Q1
$143M Sell
2,971,136
-230,925
-7% -$11.1M 1.34% 13
2020
Q4
$167M Sell
3,202,061
-1,190,135
-27% -$40.2M 2.67% 11
2020
Q3
$118M Buy
4,392,196
+4,262,157
+3,278% +$98.1M 2.18% 15
2020
Q2
$2.53M Buy
+130,039
New +$2.09M 0.05% 137

Other funds holding TGTX